Wound healing of diabetic rats treated with Moringa oleifera extract 1
dietary supplements but also as traditional treatment regimens for many diseases. So far, a large number of traditionally claimed plant medicine has been tested for diabetes and some of them have showed a promising therapeutic potential. Among these plants, a rapidly growing perennial tree, Moringa oleifera (Moringaceae family) is widely distributed in Asia, America, and Africa.
In the system of traditional Indian medicine, Moringa oleifera is considered to carry hypoglycemic activity. It is an important source of vitamin C, iron, potassium, lipids, proteins, beta-carotene, and other nutrients 6 .
The major phytochemicals present in the Moringa oleifera leaf are niazinine, niazimycin, b-sitosterol, glucomoringine, n-benzyl thiocarbamates, kaempferol, other natural antioxidant molecules including vitamins, minerals and carotenoids 7 . Some studies have been reported on the antidiabetic potential of Moringa oleifera 7, 8 . The aqueous extract is preferred for therapeutic purposes. Moringa oleifera has been investigated for its wound healing 9 , antiinflammatory, antimicrobial 10 , and antidiabetic 11 properties. The aim of this protocol is to examine if Moringa oleifera leaf aqueous extract is able to influence the healing of skin wounds of diabetic rats.
■ Methods

Plant and aqueous extract preparation
Leaves of Moringa oleifera were purchased from California Gold Nutrition. The plant material was processed into fine powder. The powder (200 g) was extracted through maceration with continuous stirring for 24 h using distilled water. The extract was filtered and lyophilized. The obtained dried aqueous extract was stored at 4°C until use.
■ Introduction
Wound healing is a complex and dynamic process involving biochemical, immunological and physiological processes in order to guarantee tissue repair 1 . Wound healing consists of an orderly progression of events. Some of them occur immediately after injury, others after a few days and some later in order to re-establish the integrity of the damaged tissue. Inflammatory, proliferation and remodeling phases happen. Alterations in any of these phases can lead to healing delay or even the inability for wound healing 
Streptozotocin-induced diabetes
A single dose of 45 mg/kg body weight of freshly prepared streptozotocin (STZ, S0130, Sigma Aldrich) in 0.1 mol/L citrate buffer (pH 4.5) was injected intraperitonealy for the induction of diabetes in overnight fasted rats. After two days of STZ treatment, diabetes mellitus was developed in the test groups, which was confirmed by assessing fasting blood glucose from the tail vein of overnight fasted rats. The dosage was performed using AccuCheck, Roche Diagnostics, Germany. Rats with blood glucose of 250 mg/dL or higher were considered to be diabetic and were included in the study.
Experimental design
Rats were allocated into four groups (6 per group). Group 1 received normal saline (NS) v.o. and served as control; Group 2 received aqueous moringa extract (100 mg/ kg) v.o. (gavage) and served as sham control. Groups 3 and 4 were treated with STZ to induce diabetes. In addition to STZ treatment, Group 3 received NS and served as toxic control; Group 4 received aqueous moringa extract (100 mg/kg) v.o. (gavage) and served as test group. The wounds of groups 1 and 3 rats were topically treated with NS; 2 and 4 groups rats were topically treated with 200µL of 10% aqueous moringa extract. The topical and oral treatments started in the same day in groups 2 and 4.
After anesthesia by ketamine 80 mg/kg and xylazine 7mg/kg i.p., the back of animals were shaved and antisepsis was performed with 70% alcohol. Skin square excision wounds sized 1.5cm 2 were made in all rats. The wounds were analyzed at 2 th , 5 th and 10 th days and wound area contractions were measured by using a picture photographed 15 cm distant from the animal dorsal skin (Sony CyberShot HD camera, Japan). Percentage reduction of initial wound area was calculated, by using the ImagePro Plus 6.0 software.
On the 10th day, blood glucose was measured again, and blood was collected by cardiac puncture for cytokines dosing. Blood was centrifuged and the serum separated for TNF-α, IL-1β, IL-6 dosing by the ELISA technique using PeproTec kits, USA, according to manufacturer's instructions. Then, the rats were euthanized with overdose of thiopental (100 mg/kg i.p.).
Histopathological study
Harvested skin wounds specimens from treated and untreated rats. The fresh tissue was sectioned into 5 mm thickness fragments and washed in running water allowing rapid and uniform action of the fixative solutions. Samples were fixed in 10% buffered formaldehyde for a maximum period of 48 hours, then processed for 18 hours in an automated tissue processor using Leica TP 1020 equipment. Prior to paraffin inclusion, the processed fragments were cut with punch-type equipment, in the gauge of 06 mm, for standardization of samples.
The histological sections were cut with Leica RM 2125 RTS microtome, at a thickness of 4 microns, in previously silanized slides. Fixed samples were stained by hematoxylin /eosin and Masson's trichrome histochemical technique, for morphological analysis in microscope (Olympus BX50, Japan). Quantitative evaluation of collagen fibers, fibroblasts, vascular neoformation and macrophages was performed using the ImagePro Plus 6.0 software (Rockville, MD, USA). Five microscopic fields of 5 slides per group were analyzed, and the mean of the scores obtained for each group was calculated. The results were expressed as mean±standard deviation.
Statistical analysis
A comparison was made between groups and the results were analyzed statistically using multi-way ANOVA. The Kruskal Wallis test and Dunn's test were also used to compare the differences between treated groups and controls. The differences were considered significant at p<0.05.
■ Results
Evolution of glycemia with treatments
In Table 1 it can be observed that in the control group and in diabetes group treated with normal saline, there was no significant difference between the levels of glycemia on the second day of dosing and on the 10th day. (p>0.05). When the animals were treated with moringa extract (ME), there was a significant reduction in glycemia, comparing the 2nd day with the 10th day of treatment in the C/ME and DIAB/ME groups (p<0.05). 
Percent reduction of wound area
In groups treated with Moringa oleifera aqueous extract (both control group and diabetic group) we observed a higher percent contraction of the wounds on 2 nd , 5 th and 10 th days, when compared with the wounds treated with normal saline ( Table 2 ). The differences were significant (p<0.05). 
C, control; ME, Moringa extract; DIAB, Diabetes; NS, normal saline. Measures followed of the same letter in the same column differ significantly (p<0.05).
Serum cytokine dosage
The expression of TNF-α, IL-1β and IL-6 occurred in a significantly lower level in the serum of control rats treated with moringa aqueous extract than in controls treated with saline. Diabetic rats treated with normal saline had TNF-α, IL-1β and IL-6 serum expression higher than in those receiving moringa aqueous extract v.o. in each group. These data are summarized in Table 3 . 
Histopathology
After quantitative evaluation of collagen fibers, fibroblasts, vascular neoformation and macrophages carried out using the ImagePro Plus 6.0 software, we observed that the score of control group rats treated with moringa extract (274±11.8) was higher than the score of control group rats treated with normal saline (186±8.3). The same occurred in diabetic animals. The score of the animals treated with moringa extract (198±13.7) was higher than in the diabetic rats treated with normal saline (145±10.5). The difference was significant (p<0.05). The scores of diabetic groups were significantly lower than the control groups. These data are summarized in Table 4 . C, control; ME, Moringa extract; DIAB, Diabetes; NS, normal saline. Measures followed of the same letter in the same column differ significantly (p<0.05, Tukey test).
■ Discussion
The present experimental model of cicatrization of skin wounds in rats, performed after induction of diabetes by streptozotocin, was done with the purpose of analyzing the effects of a phytotherapeutical on healing. We studied the evolution of the lesion area over time and we found that the effect of the Moringa oleifera extract was positive in reducing the wound area up to the 10th day when compared to the controls, treated with normal saline. We have speculated that this favorable effect occurred for some reasons. Firstly, the reduction that occurred in glycemia of diabetic animals after treatment with Moringa oleifera extract. In fact, we had the initiative to treat the animals in two ways: the first, by oral extract (gavage) and the second by topical application in skin wounds. The systemic use should have contributed to the reduction of glycemia in the animals of groups 3 and 4, with diabetes induced by streptozotocin. Consequently, improving the healing process. Topical use certainly had an additional effect on the wounds healing.
Macrophages are the main cells that influence the wound healing process. They are very active phagocytes that remove foreign bodies, bacteria and have direct granular tissue development. Then, fibroblasts appear deriving from perivascular cells of the injured tissues and endothelial cells migrate towards the wound increasing tissue permeability and collagen fiber production. The events of this phase are fibroblast proliferation, subsequent collagen synthesis and reduction in vascularization by a contraction process 1 . All these mechanisms must have been stimulated by the Moringa oleifera extract. In the present study, the histopathological examination quantitatively analyzed neovascularization, fibroblasts, macrophages and collagen fibers. We observed that in the groups of diabetic and nondiabetic animals, the systemic and topical treatment with the Moringa oleifera extract positively influenced the quantification of the histological scores. It is known that neovascular tissue and macrophages carry chemical mediators, such as cytokines, enzymes, oxygen and vitamins that are essential to establish high quality fibroblast for collagen synthesis and maturation 12 . Therefore, fibroblast proliferation and collagen production is a way to study the activity of drugs on healing 13 . Some models of specific inducible macrophage depletion, based on genetically modified mice, resulted in detrimental effect of pre-injury depletion of macrophages [14] [15] [16] . About macrophage depletion, mice depleted before injury and during the granulation tissue formation typically have shown a defect in reepithelialization, granulation tissue formation, angiogenesis, wound cytokine production and myofibroblast associated wound contraction 14 . Delayed wound healing is a major complication of diabetes, and if not treated, it can lead to delay healing and chronic wounds such as diabetic foot ulcers 17 . In contrast, in the present study we observed an increase in the macrophage and fibroblast population, which contributed to increasing the histological score in the animals treated with Moringa oleifera extract and to high percent wound contraction.
As an antidiabetic agent, the leaves, pods, and seeds of Moringa oleifera have been scientifically proven 11, 18 . Most of the researchers have used alcoholic or hydroalcoholic extract of Moringa oleifera leave. Nervertheless, the recommendation is that the only aqueous extract is preferable. In the present study we used aqueous extract 19 . We did not evaluate or isolate the possible therapeutic components of Moringa oleifera leaves, since the literature has a great variety of studies that did it. Antidiabetic properties of Moringa oleifera may be due to the presence of gallic acid, rutin, other flavonoids and phenolic metabolites 
■ Conclusion
Moringa oleifera extract positively influenced the healing of skin wounds in a diabetic rat model, after systemic and topical treatment.
